Autophagy Against Tuberculosis and HIV
自噬对抗结核病和艾滋病毒
基本信息
- 批准号:10092897
- 负责人:
- 金额:$ 74.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAddressAnti-Bacterial AgentsAutophagocytosisCell membraneCellsChronicClinicalDiabetes MellitusDimensionsDiseaseDisease OutbreaksDrug resistanceDrug resistance in tuberculosisEffectivenessEpidemicEquilibriumExcisionFailureFundingGoalsHIVHIV/TBHealthHomeostasisImmuneImpairmentInfectionInfectious Diseases ResearchInflammationInterventionKnowledgeLinezolidLinkLungMalnutritionMarshalMembraneMessenger RNAMetabolicMetabolic ControlMetabolismMulti-Drug ResistanceMycobacterium tuberculosisNational Institute of Allergy and Infectious DiseaseNatural ImmunityNerve DegenerationNeuraxisObesityOrganOutcomePathogenesisPathologicPatientsPatternPositron-Emission TomographyProcessPublic HealthQuality ControlRegimenResearchRiskRisk FactorsRoleSystemTBK1 geneTestingTissuesTuberculosisX-Ray Computed Tomographyadaptive immunitybactericidebasechemotherapyin vivointerestlatent infectionmacrophagemouse modelnovel therapeuticsnutritional approachpreventprogramsrepairedresponsestandard care
项目摘要
The outcome of Mycobacterium tuberculosis (Mtb) infection depends on host’s immune, metabolic and tissue-
protective responses. Autophagy is a process that contributes to all three aspects of protection against
tuberculosis (TB). The effectiveness or failure of autophagy and related processes is of direct relevance for
central issues in TB. These include collusion between tuberculosis and HIV, immunometabolism and
metabolic dysregulation in diabetes, tissue damage in the lung or other organs such as the central nervous
system, and chronic pulmonary impairment or acute conditions following completion of chemotherapy.
This project intends to define the role of autophagy and associated processes in active TB, TB latency, HIV-
TB interactions, cellular metabolism, and as a cell/tissue-protective mechanism. Specifically, in this renewal
application we will delineate how autophagy and related processes marshal metabolic and cytoprotective
responses against Mtb in active and latent infection. While defining these relationships in the context of TB,
we will uncover fundamental mechanisms of significance for diverse health and pathological states of both
basic and translational value in TB.
Based on our latest findings, we propose to focus on the endomembrane damage inflicted by Mtb in infected
macrophages, as a trigger of cascading immunopathological and immunometabolic changes in the host. We
refer to this set of cellular responses as membrane repair, removal and replacement (MERET). Autophagy is
a key aspect of MERET, but MERET also includes immunometabolic switching, of relevance for tissue
protection vs. pathogenesis, and for active TB disease vs. latency.
The specific aims are:
Aim 1 Define the in vivo role of key autophagy factors in protection against Mtb. This aim will focus on
the role of the sole integral membrane autophagy (ATG) factor, ATG9, as the ultimate test of the role of
autophagic membranes in protection against active or latent TB. We will use murine models of acute and
chronic Mtb infection to test whether autophagy prevents or favors transitions to latent infection.
Aim 2. Determine the roles of TBK1 and ATG9 during critical stages of autophagy. We will focus on
ATG9 and TBK1 and how these factors contribute to cytoplasmic homeostasis and protection against Mtb.
Points of HIV interference will be tested.
Aim 3, Define host cell responses to endomembrane damage associated with Mtb infection. We will
focus on endomembrane damage, an intriguing but poorly understood phenomenon occurring during Mtb
infection of macrophages. We will test the hypothesis that host cell membrane damage caused by Mtb is a
critical determinant of autophagic and immunometabolic control of TB.
结核分枝杆菌(Mtb)感染的结果与宿主的免疫、代谢和组织有关
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VOJO P DERETIC其他文献
VOJO P DERETIC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VOJO P DERETIC', 18)}}的其他基金
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
疾病中心的自噬、炎症和代谢 (AIM)
- 批准号:
9207186 - 财政年份:2017
- 资助金额:
$ 74.45万 - 项目类别:
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
疾病中心的自噬、炎症和代谢 (AIM)
- 批准号:
10249116 - 财政年份:2017
- 资助金额:
$ 74.45万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 74.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 74.45万 - 项目类别:
Operating Grants